RISK OF FMF DEVELOPMENT AMONG HETEROZYGOUS PATIENTS IN ARMENIAN POPULATION. Proceedings of the YSU B: Chemical and Biological Sciences, v. 50, n. 3 (241), p. 48–52, 21 Nov.2016.